← FDA Drug Approvals (Drugs@FDA)

CREXONT

NDA · New Drug Application · Sponsor: IMPAX · Approved 2024-08-07

Drug application

FDA Application #

NDA217186

Application type

New Drug Application

Brand name

CREXONT

Generic name

CARBIDOPA AND LEVODOPA

Active ingredients

CARBIDOPA; LEVODOPA

Dosage form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

IMPAX

Manufacturer

Amneal Pharmaceuticals LLC

First approval

2024-08-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown